The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.

The FDA recently announced a recall of over 7,000 bottles of duloxetine after detecting elevated levels of ...

Production of Prozac, an antidepressant, would end globally at the end of this year, drugmaker Eli Lilly and Co said in a press release yesterday after announcing in August that the drug would soon be ...

U.S. stocks are approaching records Monday ahead of a big week for profit reports from Big Tech stocks. Oil prices, meanwhile ...

Global Stuttering Therapeutics MarketThe global stuttering therapeutics market, valued at USD 43 million in 2023, is on track ...

They suggest other fast-acting antidepressants could offer a competitive challenge to J&J's drug, including Axsome Therapeutics' recently approved Auvelity (bupropion/dextromethorphan), Sage ...

The market for antidepressants is, however, getting more competitive after years of stagnation, with a string of new drugs on or approaching the market including AbbVie’s Vraylar (cariprazine ...

Although medications in this class are called antidepressants, they have effects that go beyond stabilizing a depressed mood. Antidepressants have been shown to affect many aspects of the body, ...

Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.

Utilization in fine chemical synthesis processes for the production of specialty chemicals and intermediates drives market ...

Among the notable contenders in the worldwide market for drug-free depression treatment are esteemed institutions such as ...